Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
Status:
Completed
Trial end date:
2021-06-15
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to describe the safety and tolerability of fasinumab,
including adverse events of special interest (AESIs), in patients with pain due to
radiographically-confirmed OA of the knee or hip.